Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Week in Review: Abbott exec plans exit | IVL competition heats up | ASNC favors PET | Medtech companies speak out | AI for POCUS
Saturday, January 31, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Abbott executive who led TAVR, Tendyne divisions announces exit

Chris Waddell, a medtech executive focused on various structural heart technologies, is leaving Abbott after several years to "recharge" and pursue a new opportunity.

READ MORE >
Chris Waddell Abbott
Share on Twitter Share on Facebook Share on Linkedin

Abbott executive who led TAVR, Tendyne divisions announces exit

Share on Twitter Share on Facebook Share on Linkedin
Chris Waddell Abbott
Chris Waddell, a medtech executive focused on various structural heart technologies, is leaving Abbott after several years to "recharge" and pursue a new opportunity.
READ MORE >

IVL competition heats up as Boston Scientific enters US market

Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.

READ MORE >
The Boston Scientific Seismiq intravascular lithotripsy (IVL) system entered commercial use in the U.S. in January 2026.
Share on Twitter Share on Facebook Share on Linkedin

IVL competition heats up as Boston Scientific enters US market

Share on Twitter Share on Facebook Share on Linkedin
The Boston Scientific Seismiq intravascular lithotripsy (IVL) system entered commercial use in the U.S. in January 2026.
Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.
READ MORE >

ASNC says PET is now the preferred nuclear imaging test for CAD

Which imaging modality is better for evaluating heart patients, PET or SPECT? After years of discussions and debates, the American Society of Nuclear Cardiology is now ready to point to PET as the No. 1 choice. “There are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded," the group wrote.

READ MORE >
Imagers reviewing flurpiridaz F-18 (Flyrcado) myocardial perfusion PET images. Image from GE Healthcare
Share on Twitter Share on Facebook Share on Linkedin

ASNC says PET is now the preferred nuclear imaging test for CAD

Share on Twitter Share on Facebook Share on Linkedin
Imagers reviewing flurpiridaz F-18 (Flyrcado) myocardial perfusion PET images. Image from GE Healthcare
Which imaging modality is better for evaluating heart patients, PET or SPECT? After years of discussions and debates, the American Society of Nuclear Cardiology is now ready to point to PET as the No. 1 choice. “There are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded," the group wrote.
READ MORE >

Faster treatments, better outcomes: 5 key takeaways from new stroke guideline

The American Stroke Association's first major update in 7 years highlights the importance of coordinated care and expands patient access to critical treatments. It also includes the first detailed recommendations for treating stroke in pediatric patients.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Faster treatments, better outcomes: 5 key takeaways from new stroke guideline

Share on Twitter Share on Facebook Share on Linkedin
The American Stroke Association's first major update in 7 years highlights the importance of coordinated care and expands patient access to critical treatments. It also includes the first detailed recommendations for treating stroke in pediatric patients.
READ MORE >

Medtronic’s newest all-in-one PFA catheter gains critical approval

The all-in-one mapping and single-shot PFA catheter was developed with electrophysiologist feedback in mind. 

READ MORE >
Medtronic has secured CE mark approval for its Affera Sphere-360 catheter,
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s newest all-in-one PFA catheter gains critical approval

Share on Twitter Share on Facebook Share on Linkedin
Medtronic has secured CE mark approval for its Affera Sphere-360 catheter,
The all-in-one mapping and single-shot PFA catheter was developed with electrophysiologist feedback in mind. 
READ MORE >

Minnesota medtech companies call for ‘de-escalation’ after Alex Pretti’s death

Executives from two of the world’s largest medtech companies, Medtronic and Boston Scientific, are among the leaders calling for "state, local and federal officials to work together to find real solutions."

READ MORE >
Minnesota businesses
Share on Twitter Share on Facebook Share on Linkedin

Minnesota medtech companies call for ‘de-escalation’ after Alex Pretti’s death

Share on Twitter Share on Facebook Share on Linkedin
Minnesota businesses
Executives from two of the world’s largest medtech companies, Medtronic and Boston Scientific, are among the leaders calling for "state, local and federal officials to work together to find real solutions."
READ MORE >

Vascular surgeon accused of double murder pleads not guilty

The 39-year-old vascular surgeon allegedly killed his ex-wife and her husband on Dec. 30. If convicted, he faces the possibility of life in prison without parole.

READ MORE >
The long legal saga of Richard Paulus, a Kentucky cardiologist accused of performing unnecessary cardiac procedures, appears to still be going strong in 2022 and might be reviewed by the Supreme Court. The New York state radiologist is facing 36 misdemeanor counts for secret sexual recording without consent, according to a story in the Boston Herald.
Share on Twitter Share on Facebook Share on Linkedin

Vascular surgeon accused of double murder pleads not guilty

Share on Twitter Share on Facebook Share on Linkedin
The long legal saga of Richard Paulus, a Kentucky cardiologist accused of performing unnecessary cardiac procedures, appears to still be going strong in 2022 and might be reviewed by the Supreme Court. The New York state radiologist is facing 36 misdemeanor counts for secret sexual recording without consent, according to a story in the Boston Herald.
The 39-year-old vascular surgeon allegedly killed his ex-wife and her husband on Dec. 30. If convicted, he faces the possibility of life in prison without parole.
READ MORE >

Robotic cardiac surgery building momentum thanks to RAVR, other breakthroughs

The sky may be the limit for robotic cardiac surgery in 2026 and beyond.

READ MORE >
Robotic aortic valve replacement (RAVR) is a new minimally invasive treatment option for symptomatic severe aortic stenosis (AS) that uses advanced robotic surgical systems. It has already started gaining momentum as an alternative to both surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR).
Share on Twitter Share on Facebook Share on Linkedin

Robotic cardiac surgery building momentum thanks to RAVR, other breakthroughs

Share on Twitter Share on Facebook Share on Linkedin
Robotic aortic valve replacement (RAVR) is a new minimally invasive treatment option for symptomatic severe aortic stenosis (AS) that uses advanced robotic surgical systems. It has already started gaining momentum as an alternative to both surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR).
The sky may be the limit for robotic cardiac surgery in 2026 and beyond.
READ MORE >

AI model turns POCUS images into accurate structural heart evaluations

Researchers see potential for this technology to make cardiac screening much easier for physicians who are not trained cardiologists.

READ MORE >
AISAP, an Israeli healthcare technology company focused on using artificial intelligence (AI) to enhance medical imaging results, has gained U.S. Food and Drug Administration (FDA) clearance for its new point-of-care ultrasound (POCUS) software platform, AISAP Cardio.
Share on Twitter Share on Facebook Share on Linkedin

AI model turns POCUS images into accurate structural heart evaluations

Share on Twitter Share on Facebook Share on Linkedin
AISAP, an Israeli healthcare technology company focused on using artificial intelligence (AI) to enhance medical imaging results, has gained U.S. Food and Drug Administration (FDA) clearance for its new point-of-care ultrasound (POCUS) software platform, AISAP Cardio.
Researchers see potential for this technology to make cardiac screening much easier for physicians who are not trained cardiologists.
READ MORE >

Cardiologist highlights key differences between OBLs and ASCs

Current payment policies have health systems and physicians all over the country looking to learn more about these two business models. 

READ MORE >
Samir B. Pancholy, MD, chief interventional cardiologist, Wayne Memorial Hospital in Honesdale, Pennsylvania, discusses the differences in the business models for office based labs (OBL) vs ambulatory surgical centers (ASC) and choosing the right model cardiovascular and vascular procedures. #TCT #SCAI #OBL #ASC
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist highlights key differences between OBLs and ASCs

Share on Twitter Share on Facebook Share on Linkedin
Samir B. Pancholy, MD, chief interventional cardiologist, Wayne Memorial Hospital in Honesdale, Pennsylvania, discusses the differences in the business models for office based labs (OBL) vs ambulatory surgical centers (ASC) and choosing the right model cardiovascular and vascular procedures. #TCT #SCAI #OBL #ASC
Current payment policies have health systems and physicians all over the country looking to learn more about these two business models. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup